Literature DB >> 10489807

Pathology of rectal adenocarcinoma following preoperative adjuvant radiotherapy and chemotherapy.

D C Allen1, L J Fon, J J McAleer, S T Irwin.   

Abstract

The study group comprised 13 patients (mean age 68 years) with clinically fixed and biopsy proven moderately differentiated rectal adenocarcinoma (8 high rectal, 5 low-mid rectal) who received synchronous courses of preoperative combination chemotherapy and pelvic radiotherapy (radiotherapy alone in 3 cases) over a period of 8-20 weeks prior to surgical resection. All cases showed varying degrees of mural and mesorectal fibrosis. Three cases did not differ otherwise from usual rectal adenocarcinoma while 4 had a 20-30% diminution in expected tumour area. In 6 cases tumour could not be definitely identified grossly--1 showed a 50% reduction in tumour bulk while 5 had only residual microscopic foci from 0.6-4 mm in maximum dimensions. Only 3 cases had involvement of the mesorectal circumferential radial margin. Four involved lymph nodes in 2 cases were partially hyalinised and calcified. Preoperative combination adjuvant therapy can produce marked regressive morphological changes in rectal adenocarcinoma. The implications of this are discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10489807      PMCID: PMC2449147     

Source DB:  PubMed          Journal:  Ulster Med J        ISSN: 0041-6193


  14 in total

1.  Tumour shrinkage and down staging after preoperative radiation of rectal adenocarcinomas.

Authors:  A Horn; I Morild; O Dahl
Journal:  Radiother Oncol       Date:  1990-05       Impact factor: 6.280

2.  High-dose preoperative radiation and full-thickness local excision. A new option for patients with select cancers of the rectum.

Authors:  G Marks; M M Mohiuddin; L Masoni; L Pecchioli
Journal:  Dis Colon Rectum       Date:  1990-09       Impact factor: 4.585

3.  Clinically resectable adenocarcinoma of the rectum treated with preoperative irradiation and surgery.

Authors:  W M Mendenhall; K I Bland; W R Rout; W W Pfaff; R R Million; E M Copeland
Journal:  Dis Colon Rectum       Date:  1988-04       Impact factor: 4.585

Review 4.  Chemotherapy for colorectal cancer.

Authors:  C G Moertel
Journal:  N Engl J Med       Date:  1994-04-21       Impact factor: 91.245

5.  The effects of chemotherapy on breast cancer tissue in locally advanced breast cancer.

Authors:  F Aktepe; N Kapucuoğlu; I Pak
Journal:  Histopathology       Date:  1996-07       Impact factor: 5.087

Review 6.  Perioperative radiotherapy +/- chemotherapy in rectal cancer.

Authors:  M Molls; U Fink
Journal:  Ann Oncol       Date:  1994       Impact factor: 32.976

7.  Mesorectal excision for rectal cancer.

Authors:  J K MacFarlane; R D Ryall; R J Heald
Journal:  Lancet       Date:  1993-02-20       Impact factor: 79.321

8.  Preoperative radiation therapy for locally advanced carcinoma of the rectum. Clinicopathologic correlative review.

Authors:  J D Schaldenbrand; D B Siders; G G Zainea; E T Thieme
Journal:  Dis Colon Rectum       Date:  1992-01       Impact factor: 4.585

Review 9.  The use of radiotherapy for patients with low rectal cancer: an overview of the Lyon experience.

Authors:  J P Gerard
Journal:  Aust N Z J Surg       Date:  1994-07

10.  A less toxic regimen of 5-fluorouracil and high-dose folinic acid for advanced gastrointestinal adenocarcinomas.

Authors:  P W Johnson; P I Thompson; M T Seymour; N P Deasy; R C Thuraisingham; M L Slevin; P F Wrigley
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640

View more
  2 in total

Review 1.  Has the new TNM classification for colorectal cancer improved care?

Authors:  Iris D Nagtegaal; Phil Quirke; Hans-Joachim Schmoll
Journal:  Nat Rev Clin Oncol       Date:  2011-10-18       Impact factor: 66.675

2.  The clinicopathologic relevance and prognostic value of tumor deposits and the applicability of N1c category in rectal cancer with preoperative radiotherapy.

Authors:  Xiao-Li Wei; Miao-Zhen Qiu; Yi-Xin Zhou; Ming-Ming He; Hui-Yan Luo; Feng-Hua Wang; Dong-Sheng Zhang; Yu-Hong Li; Rui-Hua Xu
Journal:  Oncotarget       Date:  2016-11-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.